Exelixis Inc
EXELHealthcare|Biotechnology|USA
$56.51
-0.60 (-1.05%)
DCF (FCF)
$29.26
Tangible Book
$7.38
Graham Number
$23.55
Earnings Power
$17.69
About
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Stock Price
+25.1%(1Y)
Pipeline Summary
152 total trials66
Phase 1
77
Phase 2
19
Phase 3
1
Phase 4
Terminated: 30Active: 28Recruiting: 37Completed: 41NOT_YET_RECRUITING: 10Withdrawn: 3SUSPENDED: 2APPROVED_FOR_MARKETING: 1
Active Trials (65)
XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma
NCT02721459Melanoma
Phase 1Active
Enrollment: 26 participants
Pan Tumor Rollover Study
NCT03899155Cancer
Phase 2Recruiting
Enrollment: 1,500 participants
Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer
NCT04963283Colorectal Adenocarcinoma
Phase 2Active
Enrollment: 48 participants
Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
NCT04289779Bladder Cancer
Phase 2Active
Enrollment: 46 participants
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06082167Head and Neck Squamous Cell Carcinoma
Phase 2Phase 3Active
Enrollment: 600 participants
BioScore
6/10
Watchlist
Ownership
Recent Insider Trades
WYSZOMIERSKI JACK LSELL
2026-06-013,925 shares @ $50.55
Eckhardt Sue GailSELL
2026-06-019,812 shares @ $50.14
Aftab DanaSELL
2026-05-2643,451 shares @ $50.35
Haley Patrick J.SELL
2026-05-2032,110 shares @ $49.81
Hefti BrendaSELL
2026-05-186,625 shares @ $50.21
Recent News
2026-07-07 16:37:55
2026-07-07 13:01:40
2026-07-02 13:36:45
2026-07-02 12:04:16
2026-06-25 14:42:09
Data last updated: Jul 12, 2026, 07:25 PM